Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Specific T cells are vital for controlling SARS-CoV-2 infection, preventing reinfection, and ensuring vaccine efficacy.
• Understanding T cell responses is key to comprehending COVID-19 immunity.

Purpose of the Study:

• To assess the polyfunctionality of SARS-CoV-2-specific CD4+ and CD8+ T cells in patients with severe/moderate COVID-19 pneumonia and in recovered individuals.
• To identify functional T cell subsets that may contribute to protection against SARS-CoV-2.

Main Methods:

• Studied patients with acute severe/moderate COVID-19 pneumonia and recovered patients (approx. 4 months post-infection).
• Assessed T cell polyfunctionality via in vitro stimulation with SARS-CoV-2 peptide pools (M, N, S proteins).
• Quantified simultaneous cytokine production (IFN-γ, TNF, IL-2, IL-17, Granzyme B) and CD107a expression in CD4+ and CD8+ T cells.

Main Results:

• Recovered patients with prior severe COVID-19 exhibited high proportions of polyfunctional antigen-specific CD4+ T cells producing Th1 and Th17 cytokines.
• A similar polyfunctional CD4+ T cell profile was observed in patients with moderate COVID-19 pneumonia.
• No significant differences in CD8+ T cell polyfunctionality were noted between groups, though higher proportions of responding cells were seen during acute infection.

Conclusions:

• Polyfunctional SARS-CoV-2-specific CD4+ T cells, particularly those producing Th1/Th17 cytokines, are characteristic of individuals who recovered from severe or moderate COVID-19.
• These findings contribute to understanding the complexity of the immune response to SARS-CoV-2 and may inform strategies for enhancing protective immunity.